Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Open in API
Filings indexed 551 across all filing types
Latest filing 2024-10-08 Regulatory Filings
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2157 characters) addressed to stock exchanges informing about a scheduled one-on-one virtual meeting (VC) with an analyst/fund manager. It references Regulation 30 and SEBI Listing Obligations, indicating it is a regulatory disclosure. The document mentions that the latest earnings and corporate presentations are already available on the company's website, but does not contain any financial data or detailed report itself. It is an announcement of an event related to investor relations rather than a financial report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure.
2024-10-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons due to the upcoming declaration of un-audited financial results for the second quarter and half year ending September 30, 2024. It references regulatory provisions related to insider trading and trading restrictions but does not contain any financial data or the actual financial results. The document is short (1682 characters) and serves as an announcement about trading restrictions ahead of a financial report, not the report itself. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-09-26 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding a clarification sought about a spurt in trading volume of the company's shares. It references a letter from the NSE and explains that the company has made all necessary disclosures as per SEBI regulations and that the volume movement is market-driven. The document is a regulatory communication clarifying market activity and compliance with disclosure obligations. It does not contain financial statements, audit information, management discussion, or any report data. It is not an announcement of voting results, nor a capital or financing update. It is a regulatory filing responding to an inquiry from the stock exchange about unusual market activity. The document length is short (1850 characters), and it is a formal regulatory communication. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-09-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the schedule of meetings with institutional investors through a Non-Deal Roadshow. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document mentions that the latest Earnings Presentation and Corporate Presentation are already available on the company's website, but does not contain any financial data or detailed presentation itself. The document is short (2344 characters) and serves as an announcement of an upcoming investor meeting schedule rather than a report or presentation. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-19 English
Shareholders meeting
Regulatory Filings
2024-09-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about an upcoming Investor/Analyst Plant Visit scheduled for specific dates. It references compliance with SEBI Listing Obligations but does not contain any financial data, report, or detailed presentation. It is an announcement informing about an event rather than a report or detailed investor presentation. The document length is only 1568 characters, which is quite short and fits the profile of a Regulatory Filing (RNS) as a general regulatory announcement. It does not fit into categories like Investor Presentation (IP) because it lacks detailed financial or strategic content, nor is it a report publication or earnings release. Therefore, the best classification is Regulatory Filings (RNS).
2024-09-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.